Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

German launch for Femara

April 21, 1997

PDT expands phase II/III trial of Purlytin

April 18, 1997

Anti-CD44 antisense oligonucleotides prepared by ICN

April 18, 1997

Natural antifungal/antitumor agents discovered by Fujisawa

April 18, 1997

Novartis prepares novel signal transduction inhibitors

April 18, 1997

U.K. launch for Campto

April 18, 1997

Sugen and Hoechst Marion Roussel enter cancer drug research agreement

April 18, 1997

Preclinical and clinical data on p53 presented at AACR

April 17, 1997

C225 effective in mouse model of human bladder cancer

April 16, 1997

ImClone reports research results from its anti-flk-1 monoclonal antibody program

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...